Skip to main content

Tachycardia, Ventricular

2
Pipeline Programs
7
Companies
10
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Medtronic
MedtronicNJ - Phillipsburg
4 programs
2
Implantable Cardiac DefibrillatorPhase 4
Implantable Cardiac DefibrillatorPhase 4
Implanted DeviceN/A
Methods for monitoring patients with ICD'sN/A1 trial
Active Trials
NCT00606567Completed151Est. May 2010
Rhythm Pharmaceuticals
3 programs
Implanted DeviceN/A1 trial
Implantable Cardiac DefibrillatorPHASE_41 trial
Implantable Cardiac DefibrillatorPHASE_41 trial
Active Trials
NCT00279279Completed700Est. May 2006
NCT00147290Completed526Est. Jan 2008
NCT00147277Completed925Est. Jan 2008
Boston Scientific
Boston ScientificCA - Valencia
3 programs
S-ICD SystemN/A1 trial
S-ICD SystemN/A1 trial
mCRM Therapy SystemN/A1 trial
Active Trials
NCT01064076Completed330Est. Jan 2013
NCT01085435Completed994Est. Jan 2024
NCT04798768Active Not Recruiting297Est. Dec 2030
Siemens Healthineers
Siemens HealthineersGermany - Forchheim
2 programs
CyberHeart SystemN/A1 trial
Varian Cardiac RadioablationN/A1 trial
Active Trials
NCT02661048Completed5Est. Jul 2023
NCT05765175Recruiting380Est. May 2030
Abbott
AbbottABBOTT PARK, IL
1 program
ICD implant + Patient Notifier turned OFFN/A1 trial
Active Trials
NCT00559559Completed362Est. Dec 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Rhythm PharmaceuticalsImplantable Cardiac Defibrillator
Rhythm PharmaceuticalsImplantable Cardiac Defibrillator
Siemens HealthineersVarian Cardiac Radioablation
Boston ScientificmCRM Therapy System
Siemens HealthineersCyberHeart System
Boston ScientificS-ICD System
Boston ScientificS-ICD System
AbbottICD implant + Patient Notifier turned OFF
MedtronicMethods for monitoring patients with ICD's
Rhythm PharmaceuticalsImplanted Device

Clinical Trials (10)

Total enrollment: 4,670 patients across 10 trials

NCT00147277Rhythm PharmaceuticalsImplantable Cardiac Defibrillator

ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy

Start: Mar 2004Est. completion: Jan 2008925 patients
Phase 4Completed
NCT00147290Rhythm PharmaceuticalsImplantable Cardiac Defibrillator

ADVANCE CRT - D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy

Start: Feb 2004Est. completion: Jan 2008526 patients
Phase 4Completed
NCT05765175Siemens HealthineersVarian Cardiac Radioablation

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

Start: Apr 2023Est. completion: May 2030380 patients
N/ARecruiting
NCT04798768Boston ScientificmCRM Therapy System

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing

Start: Jul 2021Est. completion: Dec 2030297 patients
N/AActive Not Recruiting
NCT02661048Siemens HealthineersCyberHeart System

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

Start: Feb 2015Est. completion: Jul 20235 patients
N/ACompleted
NCT01085435Boston ScientificS-ICD System

Boston Scientific Post Market Subcutaneous-Implantable Cardioverter Defibrillator (S-ICD) Registry

Start: Feb 2011Est. completion: Jan 2024994 patients
N/ACompleted
NCT01064076Boston ScientificS-ICD System

S-ICD® System IDE Clinical Study

Start: Jan 2010Est. completion: Jan 2013330 patients
N/ACompleted
NCT00559559AbbottICD implant + Patient Notifier turned OFF

PAtient NOtifier Feature for Reduction of Anxiety

Start: Dec 2007Est. completion: Dec 2010362 patients
N/ACompleted
NCT00606567MedtronicMethods for monitoring patients with ICD's

A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic

Start: Dec 2006Est. completion: May 2010151 patients
N/ACompleted
NCT00279279Rhythm PharmaceuticalsImplanted Device

PREPARE - Primary Prevention Parameters Evaluation

Start: Oct 2003Est. completion: May 2006700 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 4,670 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.